Study focus area

OUR STUDIES

ViiV POSITIVE PATHWAYS: AIDS HEALTHCARE FOUNDATION (AHF) RETENTION IN CARE

Background

The objective of this study is to evaluate the effectiveness of a specific intervention to retain HIV positive patients in care and within the same health care system. The intervention is the use of phone calls from the patient’s primary caregiver for those patients who are identified as a significant risk to loss of follow-up based upon pre-defined criteria. Also, the specific intervention proposed to re-engage patients at risk to loss of follow-up will be compared to the modest intervention used in a pilot study. The AHF specific intervention will include focused reports on the AHF patients presented to the clinic staff and they follow AHF standards of care methods in response to this data.

Doctor with patient in clinic room

Design

This project follows a hybrid design type 1 layout with the primary aim to determine the effectiveness of a clinical intervention to retain HIV positive patients in care and within the same health care system. A secondary aim is to better understand the context for implementation. A sample of 11,500 patients who are at risk to loss of follow-up were included in this study. The specific intervention proposed to re-engage patients will be compared to the modest intervention used in a pilot study where the focused reports on the AHF patients are presented to the clinic staff and they follow AHF standards of care methods in response to this data.

Primary Objective

  • To assess the clinical effectiveness of implementing phone calls from the patient’s primary caregiver for those patients who are identified as a significant risk to loss of follow-up based upon pre-defined criteria in comparison to SOC.

Results

  • Flags at intervention HCC were more likely to result in any visit or any visit within 2 months than flags at control HCCs.
  • A greater proportion of at-risk PLWH who were retained in care during the study at the intervention HCCs achieved a viral load <50 copies/mL, compared to the control HCCs.

Collaborators

Rodney Mood Michael Wohlfeiler

Setting

AHF clinics in the following locations: Brooklyn, NY, Jackson, MS, Tampa, FL, Dallas, TX, Valley/Sherman Oaks, CA

Location

U.S.A.

Duration

Dec 2019- Dec 2021

Category

Retention in Care and Adherence

Key study materials

Report

Final Report Presentation

The Positive Pathways Study: AHF Retention in Care

Download

ViiV study lead and contact

Tammeka Evans,

Director of Global Public Health and Innovation

Contact

RELATED STUDIES

Infinity%
Infinity%
USA

As part of an effort to re-engage patients into care, this study determined the effectiveness of using an outreach nurse as a direct clinical liaison through the State Bridge Counsellor (SBC) Program.

USA

As part of this project, financial incentives were used to engage and retain people living with HIV with the goal of contributing to viral suppression in the Baton Rouge, LA area.

ITALY

The RELAPP study is focused upon developing an algorithm for general practitioners in Italy to identify earlier those at risk of HIV.

Our partnerships

Our partnerships

We are proud to partner with multiple organizations that work to prevent HIV and improve the lives of people who live with HIV.

Find out more

NP-GBL-HVU-WCNT- 210112 | March 2022

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.